Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.21.4
CONDENSED BALANCE SHEETS - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash $ 475,056 $ 6,410
Prepaid expenses 396,375 17,000
Total current assets 871,431 23,410
Deferred offering costs   439,752
Investments held in Trust Account 414,016,040  
Total Assets 414,887,471 463,162
Current liabilities:    
Accounts payable 117,263 116,374
Accrued expenses 239,332 194,520
Accounts payable - related party 120,000  
Note payable - related party   139,949
Total current liabilities 476,595 450,843
Derivative warrant liabilities 14,250,800  
Deferred underwriting commissions 14,490,000  
Total liabilities 29,217,395 450,843
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value; 500,000,000 shares authorized; 41,400,000 and 0 shares at $10.00 per share, respectively 414,000,000  
Shareholder's Equity (Deficit):    
Preferred shares, $0.0001 par value 5,000,000 shares authorized none issued and outstanding
Additional paid-in capital   23,965
Accumulated deficit (28,330,959) (12,681)
Total shareholder's equity (deficit) (28,329,924) 12,319
Total Liabilities, Class A Ordinary Share Subject to Possible Redemption and Shareholders' Equity (Deficit) 414,887,471 463,162
Class B Common Stock    
Shareholder's Equity (Deficit):    
Ordinary shares [1] $ 1,035 $ 1,035
[1] The December 31, 2020, amount included up to 1,350,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On February 9, the full amount of the over-allotment was exercised resulting in no forfeiture of shares.